These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12613191)

  • 1. Growth, survival and migration: the Trk to cancer.
    Rubin JB; Segal RA
    Cancer Treat Res; 2003; 115():1-18. PubMed ID: 12613191
    [No Abstract]   [Full Text] [Related]  

  • 2. Trk receptor inhibition induces apoptosis of proliferating but not quiescent human osteoblasts.
    Pinski J; Weeraratna A; Uzgare AR; Arnold JT; Denmeade SR; Isaacs JT
    Cancer Res; 2002 Feb; 62(4):986-9. PubMed ID: 11861369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the neurotrophin receptor TrkA down-regulates expression and function of angiogenic stimulators in SH-SY5Y neuroblastoma cells.
    Eggert A; Grotzer MA; Ikegaki N; Liu XG; Evans AE; Brodeur GM
    Cancer Res; 2002 Mar; 62(6):1802-8. PubMed ID: 11912158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On Trk for retrograde signaling.
    Miller FD; Kaplan DR
    Neuron; 2001 Dec; 32(5):767-70. PubMed ID: 11738023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trk receptors.
    Deinhardt K; Chao MV
    Handb Exp Pharmacol; 2014; 220():103-19. PubMed ID: 24668471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1.
    Miranda C; Greco A; Miele C; Pierotti MA; Van Obberghen E
    J Cell Physiol; 2001 Jan; 186(1):35-46. PubMed ID: 11147812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dependence receptors: the trophic theory revisited.
    Mehlen P
    Sci Signal; 2010 Dec; 3(151):pe47. PubMed ID: 21139137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Trk signaling pathways by the cholestane amide conjugate MCC-257.
    Yamada MK; Konishi Y; Kakinoki B; Ikegami K; Setou M
    J Pharmacol Sci; 2008 Sep; 108(1):131-4. PubMed ID: 18758136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-trk inhibition decreases metastasis and enhances host survival in experimental models as a result of its selective induction of apoptosis of prostate cancer cells.
    Weeraratna AT; Dalrymple SL; Lamb JC; Denmeade SR; Miknyoczki S; Dionne CA; Isaacs JT
    Clin Cancer Res; 2001 Aug; 7(8):2237-45. PubMed ID: 11489797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological effects of TrkA and TrkB receptor signaling in neuroblastoma.
    Schramm A; Schulte JH; Astrahantseff K; Apostolov O; Limpt Vv; Sieverts H; Kuhfittig-Kulle S; Pfeiffer P; Versteeg R; Eggert A
    Cancer Lett; 2005 Oct; 228(1-2):143-53. PubMed ID: 15921851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The signaling adapters fibroblast growth factor receptor substrate 2 and 3 are activated by the thyroid TRK oncoproteins.
    Ranzi V; Meakin SO; Miranda C; Mondellini P; Pierotti MA; Greco A
    Endocrinology; 2003 Mar; 144(3):922-8. PubMed ID: 12586769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice.
    Miknyoczki SJ; Wan W; Chang H; Dobrzanski P; Ruggeri BA; Dionne CA; Buchkovich K
    Clin Cancer Res; 2002 Jun; 8(6):1924-31. PubMed ID: 12060637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zinc-mediated neuronal death is dependent on Trk activation.
    Morley SN; Power JM; Coulson EJ; Bartlett PF
    Exp Neurol; 2007 Jun; 205(2):360-6. PubMed ID: 17433297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cell death-survival equation.
    Benz EJ; Nathan DG; Amaravadi RK; Danial NN
    Clin Cancer Res; 2007 Dec; 13(24):7250-3. PubMed ID: 18094404
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurogenesis in the adult ischemic brain: generation, migration, survival, and restorative therapy.
    Zhang RL; Zhang ZG; Chopp M
    Neuroscientist; 2005 Oct; 11(5):408-16. PubMed ID: 16151043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G-protein-coupled receptors, cell motility and proliferation.
    Lümmen G; Rübben H
    Urol Int; 2003; 71(1):1-7. PubMed ID: 12845251
    [No Abstract]   [Full Text] [Related]  

  • 17. Neuregulin-1 and myelination.
    Lemke G
    Sci STKE; 2006 Mar; 2006(325):pe11. PubMed ID: 16522871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
    Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
    Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rational basis for Trk inhibition therapy for prostate cancer.
    Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
    Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination.
    Arévalo JC; Waite J; Rajagopal R; Beyna M; Chen ZY; Lee FS; Chao MV
    Neuron; 2006 May; 50(4):549-59. PubMed ID: 16701206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.